CRISPR Therapeutics AG


Market Cap$5.34B

Compare CRISPR Therapeutics AG

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CRISPR Therapeutics AGCRISPR Therapeutics AG-34.80%-8%15.2-
marketMarket Avg58.91.26%30%-1
HealthcareHealthcare Avg64.71.29%15%7.30.9

Current Fair Value

26.7% upside

Undervalued by 26.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$5.34 Billion
Enterprise Value$3.65 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.94
Outstanding Shares84,883,091
Avg 30 Day Volume1,336,254


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-34.76
Price to Sales15.17
Price to Book Ratio2.76
Enterprise Value to Revenue9.82
Enterprise Value to EBIT-16.39
Enterprise Value to Net Income-24
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About CRISPR Therapeutics AG

CEO: Samarth Kulkarni